Coloplast A/S CLPBF Stock
Coloplast A/S Price Chart
Coloplast A/S CLPBF Financial and Trading Overview
Coloplast A/S stock price | 103.52 USD |
Previous Close | 121.9 USD |
Open | 122.24 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 121.9 - 121.9 USD |
52 Week Range | 95.75 - 145.05 USD |
Volume | 366 USD |
Avg. Volume | 71 USD |
Market Cap | 26.03B USD |
Beta (5Y Monthly) | 0.283908 |
PE Ratio (TTM) | 37.27829 |
EPS (TTM) | 3.15 USD |
Forward Dividend & Yield | 2.85 (2.33%) |
Ex-Dividend Date | May 15, 2023 |
1y Target Est | 16.13 USD |
CLPBF Valuation Measures
Enterprise Value | 46.9B USD |
Trailing P/E | 37.27829 |
Forward P/E | 29.58738 |
PEG Ratio (5 yr expected) | 163.43 |
Price/Sales (ttm) | 1.081094 |
Price/Book (mrq) | 3.681111 |
Enterprise Value/Revenue | 1.948 |
Enterprise Value/EBITDA | 6.034 |
Trading Information
Coloplast A/S Stock Price History
Beta (5Y Monthly) | 0.283908 |
52-Week Change | 18.07% |
S&P500 52-Week Change | 20.43% |
52 Week High | 145.05 USD |
52 Week Low | 95.75 USD |
50-Day Moving Average | 133.09 USD |
200-Day Moving Average | 119.88 USD |
CLPBF Share Statistics
Avg. Volume (3 month) | 71 USD |
Avg. Daily Volume (10-Days) | 100 USD |
Shares Outstanding | 194.31M |
Float | 130.82M |
Short Ratio | N/A |
% Held by Insiders | 35.90% |
% Held by Institutions | 26.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 20 |
Trailing Annual Dividend Yield | 16.40% |
5 Year Average Dividend Yield | 200.99% |
Payout Ratio | 0.885 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | 19.94% |
Operating Margin (ttm) | 29.19% |
Gross Margin | 68.08% |
EBITDA Margin | 32.28% |
Management Effectiveness
Return on Assets (ttm) | 12.46% |
Return on Equity (ttm) | 67.11% |
Income Statement
Revenue (ttm) | 24.07B USD |
Revenue Per Share (ttm) | 113.37 USD |
Quarterly Revenue Growth (yoy) | 10.19% |
Gross Profit (ttm) | 15.53B USD |
EBITDA | 7.77B USD |
Net Income Avi to Common (ttm) | 4.8B USD |
Diluted EPS (ttm) | 3.27 |
Quarterly Earnings Growth (yoy) | 17.89% |
Balance Sheet
Total Cash (mrq) | 644M USD |
Total Cash Per Share (mrq) | 3.03 USD |
Total Debt (mrq) | 21.65B USD |
Total Debt/Equity (mrq) | 307.76 USD |
Current Ratio (mrq) | 0.988 |
Book Value Per Share (mrq) | 33.115 |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.89B USD |
Levered Free Cash Flow (ttm) | 3.36B USD |
Profile of Coloplast A/S
Country | United States |
State | N/A |
City | Humlebæk |
Address | Holtedam 1-3 |
ZIP | 3050 |
Phone | 45 49 11 11 11 |
Website | https://www.coloplast.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 14973 |
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Q&A For Coloplast A/S Stock
What is a current CLPBF stock price?
Coloplast A/S CLPBF stock price today per share is 103.52 USD.
How to purchase Coloplast A/S stock?
You can buy CLPBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Coloplast A/S?
The stock symbol or ticker of Coloplast A/S is CLPBF.
Which industry does the Coloplast A/S company belong to?
The Coloplast A/S industry is Medical Instruments & Supplies.
How many shares does Coloplast A/S have in circulation?
The max supply of Coloplast A/S shares is 222.72M.
What is Coloplast A/S Price to Earnings Ratio (PE Ratio)?
Coloplast A/S PE Ratio is 32.86349000 now.
What was Coloplast A/S earnings per share over the trailing 12 months (TTM)?
Coloplast A/S EPS is 3.15 USD over the trailing 12 months.
Which sector does the Coloplast A/S company belong to?
The Coloplast A/S sector is Healthcare.